Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Do markers of bone turnover predict clinical outcome in patients with bone metastases?

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 258–259 (2006)Cite this article

boxed-textColeman RE et al. (2005) Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid. J Clin Oncol 23: 4925–4935

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Roudier MP et al. (2003) Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum Pathol 34: 646–653

    Article  Google Scholar 

  2. Seibel MJ (2005) Clinical use of markers of bone turnover in metastatic bone disease. Nat Clin Pract Oncol 2: 504–517

    Article  CAS  Google Scholar 

  3. Brown JE et al. (2005) Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst 97: 59–69

    Article  CAS  Google Scholar 

  4. Schneider A et al. (2005) Bone turnover mediates preferential localization of prostate cancer in the skeleton. Endocrinology 146: 1727–1736

    Article  CAS  Google Scholar 

  5. van der Pluijm G et al. (2005) Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo. Cancer Res 65: 7682–7690

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. the Gerald D Aurbach Professor of Endocrinology at the University of Virginia, Charlottesville, VA, USA

    Theresa A Guise

Authors
  1. Theresa A Guise
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Theresa A Guise.

Ethics declarations

Competing interests

Dr. Guise has received research grants from Novartis, Scios, Astrazeneca and Fibrogen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guise, T. Do markers of bone turnover predict clinical outcome in patients with bone metastases?. Nat Rev Endocrinol 2, 258–259 (2006). https://doi.org/10.1038/ncpendmet0171

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0171

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing